Status:
COMPLETED
Detection and Analysis of MBC With Heterogeneous ER Expression
Lead Sponsor:
Fudan University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
To investigate the treatment pattern and efficacy of MBC patients with ER heterogeneity using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PE...
Eligibility Criteria
Inclusion
- Patients received 18F-FES PET/CT in Fudan University Shanghai Cancer Center from 2017-2021.
- Patients had both FES positive (FES+) and negative (FES-) lesions in FES exam.
- Patients received further treatment.
Exclusion
- Incomplete medical records.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT05392985
Start Date
January 15 2022
End Date
December 15 2022
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032